Shouhui Zhu
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer.
Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 04, 2025
Radiogenomics models for predicting prognosis in locally advanced non-small cell lung cancer patients undergoing definitive chemoradiotherapy.
Journal: Translational lung cancer research
Published: March 04, 2024
Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.
Journal: Biomarker research
Published: February 18, 2023
Effectivity of involved-field radiotherapy for recurrent brain metastasis in patients with small-cell lung cancer.
Journal: Journal of cancer research and therapeutics
Published: October 07, 2022
Use CT Imaging to Predict the Short-Term Outcome of Concurrent Chemoradiotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma.
Journal: Dose-response : a publication of International Hormesis Society
Published: August 21, 2019
Tumor suppressor p53 induces miR-15a processing to inhibit neuronal apoptosis inhibitory protein (NAIP) in the apoptotic response DNA damage in breast cancer cell.
Journal: American journal of translational research
Published: June 30, 2016
A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
Journal: PloS one
Published: March 15, 2016
A randomized phase II study of erlotinib plus nab-paclitaxel versus erlotinib alone as second-line therapy for Chinese patients with advanced EGFR wild-type non-small-cell lung cancer.
Journal: Cancer investigation
Published: May 08, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026